Blog

RSS Feed
Posted by Michael Wonder on 15 Dec 2021

Wales is first UK country to fund GW’s Epidyolex for tuberous sclerosis

15 December 2021 - Patients in Wales with a rare disease that causes epilepsy will be the first in the ...

Read more →
Posted by Michael Wonder on 23 Jul 2020

Vertex and NHS Wales agree on Kaftrio reimbursement

23 July 2020 - People with cystic fibrosis living in Wales should get speedy access to Vertex' new therapy following ...

Read more →
Posted by Michael Wonder on 03 Mar 2020

Strategic collaboration announced by NICE and Health Technology Wales

3 March 2020 - Collaboration outlines the strategic planning and delivery of independent and authoritative medical technology guidance. ...

Read more →